Corvus Pharmaceuticals
CRVS
CRVS
62 hedge funds and large institutions have $159M invested in Corvus Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 3 closing their positions.
Holders
62
Holders Change
+15
Holders Change %
+31.91%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
18
Increased
18
Reduced
9
Closed
3
Calls
$6.07M
Puts
$538K
Net Calls
+$5.54M
Net Calls Change
+$5.49M
Top Buyers
| 1 |
VC
1
Vivo Capital
Palo Alto,
California
|
$7.91M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$12.8M |
| 3 |
GTC
3
Ghost Tree Capital
New York
|
$2.64M |
| 4 |
4
Goldman Sachs
New York
|
$1.99M |
| 5 |
SSA
5
Schonfeld Strategic Advisors
New York
|
$1.75M |
Top Sellers
| 1 |
SC
1
Samlyn Capital
New York
|
$23.9M |
| 2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$29.4M |
| 3 |
TL
3
TowerView LLC
New York
|
$620K |
| 4 |
4
Renaissance Technologies
New York
|
$2.04M |
| 5 |
5
Two Sigma Advisers
New York
|
$324K |
